Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ethan Rubinstein

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
The Journal of Antimicrobial Chemotherapy|April 17, 2013
Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitalsHeather J Adam, Melanie R Baxter, Ross J Davidson, et al.
BMC Public Health|June 3, 2014
Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigationAmy Schneeberg, Julie A Bettinger, Shelly McNeil, et al.
International Journal of Antimicrobial Agents|July 30, 2013
Telavancin versus vancomycin for bacteraemic hospital-acquired pneumoniaMartin E Stryjewski, Steven L Barriere, Ethan Rubinstein, et al.
Expert Review of Anti-Infective Therapy|April 20, 2012
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacinGeorge G Zhanel, Christopher D Lawson, Sheryl Zelenitsky, et al.
Drugs|February 2, 2013
Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combinationGeorge G Zhanel, Christopher D Lawson, Heather Adam, et al.
Drugs|December 20, 2013
Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilliGeorge G Zhanel, Phillip Chung, Heather Adam, et al.
Plos Medicine|December 29, 2007
Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendationsJavier Ariza, Mile Bosilkovski, Antonio Cascio, et al.
The Lancet. Infectious Diseases|December 22, 2006
Anti-infective research and development--problems, challenges, and solutionsJohn S Bradley, Robert Guidos, Steve Baragona, et al.
Human Vaccines & Immunotherapeutics|July 11, 2013
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparisonDavid W Scheifele, Shelly A McNeil, Brian J Ward, et al.
Emerging Infectious Diseases|January 23, 2014
Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adultsKatherine A Hendricks, Mary E Wright, Sean V Shadomy, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|April 17, 2013
Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitalsHeather J Adam, Melanie R Baxter, Ross J Davidson, et al.
BMC Public Health|June 3, 2014
Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigationAmy Schneeberg, Julie A Bettinger, Shelly McNeil, et al.
International Journal of Antimicrobial Agents|July 30, 2013
Telavancin versus vancomycin for bacteraemic hospital-acquired pneumoniaMartin E Stryjewski, Steven L Barriere, Ethan Rubinstein, et al.
Expert Review of Anti-Infective Therapy|April 20, 2012
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacinGeorge G Zhanel, Christopher D Lawson, Sheryl Zelenitsky, et al.
Drugs|February 2, 2013
Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combinationGeorge G Zhanel, Christopher D Lawson, Heather Adam, et al.
Drugs|December 20, 2013
Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilliGeorge G Zhanel, Phillip Chung, Heather Adam, et al.
Plos Medicine|December 29, 2007
Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendationsJavier Ariza, Mile Bosilkovski, Antonio Cascio, et al.
The Lancet. Infectious Diseases|December 22, 2006
Anti-infective research and development--problems, challenges, and solutionsJohn S Bradley, Robert Guidos, Steve Baragona, et al.
Human Vaccines & Immunotherapeutics|July 11, 2013
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparisonDavid W Scheifele, Shelly A McNeil, Brian J Ward, et al.
Emerging Infectious Diseases|January 23, 2014
Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adultsKatherine A Hendricks, Mary E Wright, Sean V Shadomy, et al.
Pageof 10